Papillary Transitional Cell Carcinoma
NCI Definition: A non-invasive or invasive transitional cell carcinoma characterized by a papillary growth pattern. It may occur in the bladder or the renal pelvis. 
There is 1 clinical trial for papillary transitional cell carcinoma, of which 1 is open and 0 are completed or closed. Of the trial that contains papillary transitional cell carcinoma as an inclusion criterion, 1 is phase 2 (1 open).
Nilotinib and paclitaxel are the most common interventions in papillary transitional cell carcinoma clinical trials.
2. The AACR Project GENIE Consortium. AACR Project GENIE: powering precision medicine through an international consortium. Cancer Discovery. 2017;7(8):818-831. Dataset Version 8. This dataset does not represent the totality of the genetic landscape; see paper for more information.